EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Beyond Upper Airway Involvement: Evidence of Intrinsic Lung Disease in a Mouse Model of Mucopolysaccharidosis I

Martin Donnelley, Ronan Smith, Patricia Cmielewski, Nicole Reyne, Piraveen Pirakalathanan, Nina Eikelis iD, Kris Nilsen, Jennie Louise, Kate Barratt, Jessica Logan iD, Ben Ung, David Parsons und 3 weitere

Journal of Inherited Metabolic Disease · 2026-07 · 49 (4)

DOI: 10.1002/jimd.70219 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 30.06.2026. Verfasst von Martin Donnelley und 14 weiteren Autor:innen. Beteiligte Einrichtung: Robinson Research Institute, Adelaide University, Adelaide, South Australia. Hauptthemen laut MEDLINE: Mucopolysaccharidosis I, Lung, Lung Diseases. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National MPS Society, Medical Research Future Fund Grant, Cystic Fibrosis Foundation Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Almost all patients with mucopolysaccharidosis (MPS) develop respiratory dysfunction of varying severity during disease progression. While respiratory disease in MPS has traditionally been attributed to upper airway obstruction caused by glycosaminoglycan (GAG) accumulation in the trachea and bronchi, involvement of the intrapulmonary conducting airways and lung parenchyma remains poorly defined. Here, we characterised lung disease in a mouse model of MPS I using a combination of non‐invasive X‐ray Velocimetry (XV) functional lung imaging and gold‐standard flexiVent respiratory mechanics testing, complemented by lung volume measurements and histological analysis. XV provides regional ventilation information across the entire lung during tidal breathing. MPS I mice demonstrated reduced mean specific ventilation (the average regional expansion of lung tissue across the respiratory cycle), driven predominantly by reduced ventilation in the inner (mediastinal‐adjacent) lung regions, with evidence of spatially heterogeneous ventilation distribution. Lung mechanics testing showed increased conducting airway resistance, increased respiratory system compliance and reduced tissue elastance, consistent with impaired elastic recoil and expiratory flow limitation. Lung volume analysis revealed reduced opening pressure following degassing together with increased residual volume, functional residual capacity and vital capacity. Histological analysis demonstrated heterogeneous parenchymal architecture with regions of enlarged airspaces. Together, these findings demonstrate that respiratory dysfunction in MPS I is not limited to upper airway obstruction but also involves intrinsic abnormalities of the intrapulmonary conducting airways and lung parenchyma. This intrinsic pulmonary pathology likely contributes to obstructive lung disease and may underlie the susceptibility to respiratory failure observed in patients with MPS I.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mucopolysaccharidosis ILungLung DiseasesAnimalsDisease Models, AnimalMiceRespiratory MechanicsGlycosaminoglycansAirway ResistanceMice, Inbred C57BL

Stichwörter der Autor:innen

Hurler syndromePermetiumX‐ray velocimetryanimal modelsflexiVentlung diseaselung functionmucopolysaccharidosis

Substanzen

Glycosaminoglycans

Autor:innen und Institutionen

  • Robinson Research Institute, Adelaide University, Adelaide, South Australia.
  • School of Medicine, College of Health, Adelaide University, Adelaide, South Australia.
  • Respiratory and Sleep Medicine, Women's and Children's Hospital, Adelaide, South Australia.
  • 4DMedical, Melbourne, Australia.
  • Biostatistics Unit, South Australian Health and Medical Research Institute, Adelaide, South Australia.
  • Mechanisms in Cell Biology and Disease Research Concentration, School of Pharmacy and Biomedical Sciences, College of Health, Adelaide University, Adelaide, South Australia.

ORCID-Profile: Nina Eikelis, Jessica Logan

Förderung

  • National MPS Society
  • Medical Research Future Fund Grant
  • Cystic Fibrosis Foundation Grant
  • Australia's Economic Accelerator

Zitieren

APA

Donnelley, M., Smith, R., Cmielewski, P., Reyne, N., Pirakalathanan, P., Eikelis, N., Nilsen, K., Louise, J., Barratt, K., Logan, J., Ung, B., Parsons, D., Brooks, D., Orgeig, S., & Parkinson-Lawrence, E. (2026). Beyond Upper Airway Involvement: Evidence of Intrinsic Lung Disease in a Mouse Model of Mucopolysaccharidosis I. Journal of Inherited Metabolic Disease, 49(4). https://doi.org/10.1002/jimd.70219

Vancouver

Donnelley M, Smith R, Cmielewski P, Reyne N, Pirakalathanan P, Eikelis N, et al. Beyond Upper Airway Involvement: Evidence of Intrinsic Lung Disease in a Mouse Model of Mucopolysaccharidosis I. Journal of Inherited Metabolic Disease. 2026;49(4). doi:10.1002/jimd.70219

BibTeX
@article{Donnelley2026,
  author = {Donnelley, Martin and Smith, Ronan and Cmielewski, Patricia and Reyne, Nicole and Pirakalathanan, Piraveen and Eikelis, Nina and Nilsen, Kris and Louise, Jennie and Barratt, Kate and Logan, Jessica and Ung, Ben and Parsons, David and Brooks, Doug and Orgeig, Sandra and Parkinson-Lawrence, Emma},
  title = {Beyond Upper Airway Involvement: Evidence of Intrinsic Lung Disease in a Mouse Model of Mucopolysaccharidosis I},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2026},
  volume = {49},
  number = {4},
  doi = {10.1002/jimd.70219}
}
Kostenlos starten →